KRAS and rectal cancer: The results showed that age, CEA, CA19-9, CA125, preoperative chemotherapy, macropathology type, tumor size, differentiation status, T stage, N stage, lymphovascular invasion, KRAS mutation, and postoperative chemotherapy were associated with the prognosis of patients with rectal cancer.